Lecture 17_Variations in Drug Responses Flashcards
If a normal dose of a drug is prescribed why do some patients show either too much or too little response?
- Compliance: Did patient take drug?
- Bioavailability: If drug was taken properly, was it absorbed properly and delivered to the systemic circulation?
- Pharmacokinetics: Was the drug distributed normally in the body?
- Pharmacodynamics? Did target tissue respond to drug in the expected manner?
Why is patient compliance an issue?
- Duration of treatment: There is lowered compliance for drugs that must be taken for a long time.
- Complexity of the dosing regimen (inconvenience): Ameliorated somewhat by marketing of pharmaceutical mixtures (two drugs in one dose) but this results in loss of therapeutic flexibility.
- Patient’s perception of the seriousness of the disease and of the importance and efficacy of treatment.
- Side effects of therapy, if serious, tend to decrease compliance.
- Continuity and ease of contact with physician.
Why is noncompliance a serious problem in the treatment of hypertension?
- High blood pressure itself does not cause symptoms but antihypertensives often make patients feel miserable. This decreases drug-taking compliance.
- Compliance was increased by allowing a test group of subjects to measure their own BP readings daily (reinforced with biweekly physician supervision).
Important measures to assure compliance in long-term therapies include:
- Simplified dosing schedules
- use of long-acting rather than short-acting drugs
- Minimizing side effects
- Continuous supervision of the patient
- Patient education
Factors affecting bioavailability
- GI or liver pathology (eg. diarrhea, biliary obstruction, hypermotility, reduced GI blood flow).
- Formulation of the drug preparation, leading to differences in release of drug into GI fluids.
(T/F) Generic drugs are just as good as brand name.
FALSE. Brand names are often (but not always) better formulated than generic drugs, giving more uniform and better bioavailability.
Pharmacokinetic reasons for variability to drug response.
- Liver disease may affect metabolism.
- Age (eg., elimination rate of mecillinam is 4 times slower in elderly).
- Smoking
(T/F) Pharmacokinetic variation is most evident in early infancy and advanced age, but may also be affected by disease processes at any age.
TRUE.
Give an example of a disease process affecting pharmacokinetic variation.
Penicillin, and other antibiotics, do not normally cross the blood brain barrier. However inflammatory processes (eg. meningitis) increase antibiotic permeability, increasing their effectiveness. But… this may also increase the risk for toxicity (high concentrations of penicillin can cause seizures).
In adults, drug dosing is generally calculated on the basis of…
…body size and body composition (lean body mass).
Most differences in drug doses between men and women are due to…
…different body composition.
Obese vs lean with Pm/b drugs.
- Obese person requires smaller dose of low Pm/b drug than lean person of same weight.
- Obese person requires higher dose of high Pm/b drug than skinny person of same weight (fat acts as a drug reservoir).
The required dose is proportional to…
…metabolic rate.
Metabolic rate is proportional to…
…body surface area (NOT body weight).
The required dose is actually more proportional to the metabolic rate, which is in turn closely proportional to body surface area than body weight. Why is this discrepancy important?
It’s not in adults, but it is in babies and small children whose surface area to mass ratio is considerably higher than adults.